Skip to content

Influence of caregivers of cardiology patients on the medicationprocess and their impact on adherence

Influence of caregivers of cardiology patients on the medicationprocess and their impact on adherence - CardioPharmCare explorative

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00035346
Enrollment
45
Registered
2025-01-15
Start date
2024-01-01
Completion date
Unknown
Last updated
2026-03-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Non-Adherence

Interventions

Group 1: Cardiology patients are asked about adherence, medication knowledge and medication-related burden via questionnaires during their hospital stay. Adherence is also assessed via urin analysis.

Sponsors

Universität Leipzig, Medizinische Fakultät, Insitut für Pharmazie, Abteilung für Klinische Pharmazie
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: o Written informed consent of the patient after verbal and written explanation by the attending physician supported by the study staff. o Hospitalized patients with underlying cardiological disease. o Existing long-term medication due to the underlying cardiological disease with at least one drug of ATC group C. o Over 18 years of age and fully legally competent. o Resident in own home or assisted living. o Sufficient knowledge of the German language to complete the survey.

Exclusion criteria

Exclusion criteria: - Involvement of an outpatient nurse in the medication process that goes beyond the following activities: - Weekly or daily administration of medication. - Application of exclusively parenteral forms of medication to the patient. Patient specific: - Refusal of participation by the patient. - Lack of fulfillment of the inclusion criteria. - Severe cognitive limitations that preclude participation. - Communication barriers due to physical limitations (e.g. blindness, deafness)

Design outcomes

Primary

MeasureTime frame
Patients adherence to prescribed therapy, assessed using the Stendal Adherence with Medication Score (SAMS). Determined at the only data collection point, during the inpatient stay.

Secondary

MeasureTime frame
Patients: All patient-related secondary endpoints will be collected at the single data collection point. This is during the patient's inpatient stay. 1. Patients' adherence to prescribed therapy, measured by urine analysis. 2. Patients' medication knowledge and medication-related burden, as assessed by our own questionnaire. Caregiver: All caregiver-related secondary outcomes will be collected at the only data collection point, during the patient's inpatient stay. 1. involvement of the relative in the patient's medication process o Activities performed by the relative and time spent on each activity per day and week o Total time spent per day and week 2. Carergivers medication knowledge and burden, as assessed by our own questionnaire.

Countries

Germany

Contacts

Public ContactThilo Bertsche

Universität Leipzig, Medizinische Fakultät, Insitut für Pharmazie, Abteilung für Klinische Pharmazie

thilo.bertsche@uni-leipzig.de03419711800

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Mar 14, 2026